High Signal Podcasts Evidence ledger
Method
Browse
← Back to evidence

Evidence receipt / belief

Published · transcript-backed

Ben Gilbert: belief

22 Jan 2024 Acquired Novo Nordisk (Ozempic)

“I think that the most illustrative stats on this are that the top decile of pharmaceuticals are what matters for the profits.”

— Ben Gilbert

Source trail

Everything needed to verify it.

Speaker
Ben Gilbert
Attribution
Verified speaker
Claim type
belief
Recorded
22 Jan 2024
Publisher
Acquired

Transcript context

…Four years, that's nothing. Yeah. There's no MVP in Semaglutide. Let's put a couple billion to work, and then we'll check in a couple decades later and see if we've changed the world. Obviously, there are stage gates along the way, but it's adding a zero or two to the venture business, to be honest. I think that the most illustrative stats on this are that the top decile of pharmaceuticals are what matters for the profits. If you look at the pipeline of a hundred drugs that enter clinical development, ten actually make it to market, and one provides half the profits, one drug. Oh, crap. Wow. The initial part of what you just said jives with our math earlier that 10% make it to market. That's a power law right there.…

Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.

Search evidence